IDiyas

For the Inventor, By the Inventor

San Diego, CA, United States of America

William H Romines

USPTO Granted Patents = 17

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 22(Granted Patents)


Company Filing History:

goldMedal17 out of 174 
 
Agouron Pharmaceuticals, Inc.
 patents

Years Active: 1997-2001

Loading Chart...
17 patents (USPTO):Explore Patents
1. 6323210 - Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds (2001-11-27),
2. 6207670 - Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds (2001-03-27),
3. 5981748 - Synthesis of optically pure compounds useful as GARFT inhibitors and (1999-11-09),
4. 5945427 - Antiproliferative substituted 5-thiapyrimidinone and (1999-08-31),
5. 5831100 - Syntheses of optically pure compounds useful as GARFT inhibitors and (1998-11-03),
6. 5739141 - Antiproliferative substituted 5-thiapyrimidinone and (1998-04-14),
7. 5726312 - Methods for preparing antiproliferative 5-substituted pyrimidone (1998-03-10),
8. 5723607 - Compounds useful as antiproliferative agents and GARFT inhibitors (1998-03-03),
9. 5646141 - Compounds useful as antiproliferative agents and GARFT inhibitors (1997-07-08),
10. 5641774 - Compounds useful as antiproliferative agents and garft inhibitors (1997-06-24),
11. 5641771 - Compounds useful as antiproliferative agents and garft inhibitors (1997-06-24),
12. 5639749 - Compounds useful as antiproliferative agents and garft inhibitors (1997-06-17),
13. 5639747 - Compounds useful as antiproliferative agents and garft inhibitors (1997-06-17),
14. 5625061 - Compounds useful in preparing antiproliferative agents and garft (1997-04-29),
15. 5610319 - Compound useful as antiproliferative agents and GARFT inhibitors (1997-03-11),

Title: The Innovative Contributions of William H. Romines

Introduction

William H. Romines is a prominent inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiproliferative agents. With a total of 17 patents to his name, Romines has established himself as a key figure in innovation.

Latest Patents

Romines' latest patents include novel derivatives of 5-thiapyrimidinone and 5-selenopyrimidinone compounds. These compounds are found to inhibit the enzymes glycinamide ribonucleotide formyl transferase (GARFT) and amino imidazole carboxamide ribonucleotide formyl transferase (AICARFT). The patents also disclose novel intermediates of these compounds, along with a method for preparing them. Furthermore, methods and compositions for employing these compounds as antiproliferative agents are also detailed.

Career Highlights

Romines is currently associated with Agouron Pharmaceuticals, Inc., where he continues to push the boundaries of pharmaceutical innovation. His work has been instrumental in advancing the understanding and application of antiproliferative agents in medical science.

Collaborations

Throughout his career, Romines has collaborated with notable professionals in the field, including Michael D. Varney and Cynthia Louise Palmer. These collaborations have further enriched his research and development efforts.

Conclusion

William H. Romines exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations have significantly impacted the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…